Abstract Using a conventional two-hybrid technique with MAWD as bait protein, a novel full-length cDNA was isolated and sequenced from a human liver cDNA library. This cDNA consists of 2575 base pairs and has a predicted open reading frame encoding 255 amino acids. Overall, it is similar to the catalytic enzyme PHZF, catalyzing the hydroxylation of phenazine-1-carboxylic acid to 2-hydroxyphenazine-1-carboxylic acid. Polymerase chain reactionbased mapping with both a monochromosomal hybrid panel and radiation hybrid cell panels placed the gene to human chromosome 10q21.1 near the marker D10S210.
Introduction
In this article we describe the cloning and characterization of a novel human gene that encodes a predicted protein similar to hydroxylase. We named the molecule MAWBP as it seemed to be a MAWD binding protein. MAWD was recently identified as a novel protein containing several WD-40 motifs (van der Voorn and Ploegh 1992), and it was found to promote the anchorage-independent growth of cells (Matsuda et al. 2000a) ; however, the biochemical and physiological role of MAWD has not yet been clarified. The identification and characterization of a binding protein to MAWD is necessary to elucidate the further precise mechanisms of its cellular function. Accordingly, we tried to identify potential MAWD partners. The use of the yeast twohybrid system enabled us to isolate MAWBP. Other commonly used protein binding assays have not confirmed the interaction at present. However, as MAWBP had never been described before, this prompted us to further characterize the gene.
Methods, results, and discussion
We used the two WD-40 repeats region (a.a. 214 to 350) of human MAWD for bait plasmids in the yeast two-hybrid screens, and identified a clone from a cDNA library constructed from human liver poly (A)ϩRNA. The clone cDNA was reconfirmed to be interaction-positive by using an independent yeast clone containing the bait. The positive clones contained insert sequences with the metallothionein gene (accession number, V00594), the S-protein gene (accession number, X03168) and an unknown gene; however, the metallothionein and the S-protein were fused to the GAL4 in a frameshift manner. This prompted us to characterize further the last unknown gene whose product seemed to be fused to GAL4 in a proper frame manner. DNA sequencing of the insert region with the unknown sequence was then performed, using a Sequenase Kit (Amersham, Cleveland, OH, USA) and an automatic sequencer for dideoxy sequencing (Amersham, Cleveland, OH, USA), according to the supplier's instructions. We used the insert nucleotide sequences for further screening to isolate a fulllength clone and for searching the gene database to confirm the sequence and the gene structure (Matsuda et al. 1996; Miyazaki et al. 2000) . The determined nucleotide sequence and predicted amino acid sequence are shown in Fig. 1A . The cDNA of 2575bp contains an open reading frame of 765 bp. The MAWBP protein was then predicted to consist of 255 amino acids. There is a potential ATG start codon favored (Kozak 1989 ) from position 165 (Fig. 1A) . A human genomic sequence that is, presumably, identical to the MAWBP gene, has already been registered in GenBank (AC016395) and there are two differences, on nucleotide (nt) 359 and nt 2047. At present, we can not rule out the Fig. 1A,B Residues of the proteins, indicated by plus (ϩ), represent similar amino acid residues, and gaps are indicated by dashes. The oneletter amino acid code is used A B possibility that either a polymorphism or a mutation may exist at this site.
Searching the protein database (SWALL and PIR) revealed that MAWBP had high homology to several other proteins. The amino acid sequence of MAWBP was most homologous to that of T04A11.2 (37% identical and 55% similar) of Caenorhabditis elegans. The amino acid sequences in these proteins were compared (Fig. 1B) . How-ever, the alignment of the deduced amino acid sequence of MAWBP with the conceptual translation of genes from various species showed that the MAWBP seemed to be highly conserved throughout evolution from single-cell to higher eukaryotes, such as CAB77771, BAB04002, AAG06158, AAG18908, and AAB82044 (data not shown). It is amazing that the biochemical functions of all these proteins basically remain elusive. Because one of these homologous proteins is the catalytic enzyme PHZF (accession number; AAD15343; 37% identical and 50% similar to overall MAWBP), which is suspected to catalyze the hydroxylation of phenazine-1-carboxylic acid to 2-hydroxyphenazine-1-carboxylic acid, we speculate that MAWBP may serve as a similar catalyzing enzyme. In order to understand the biological functions of MAWBP, it is important to confirm the enzymatic activity and to identify the MAWBP binding protein, excepting MAWD.
The tissue distribution of MAWBP transcripts in various tissues was examined by using cycle-limited reverse transcription-coupled polymerase chain reaction (RT-PCR), as described previously (Seki et al. 1999; Matsuda et al. 2000b) . Primers used for RT-PCR correspond to the coding region of the gene (the expected product corresponds to nt 803 to 979). Template-cDNAs from the human tissues were purchased from Clontech (Palo Alto, CA, USA), and ten nanograms of each cDNA was used in the experiment. As shown in Fig. 2 , expression of MAWBP mRNA was detected in brain, heart, lung, liver (most obvious), pancreas (obvious), kidney (obvious), and placenta, but not in skeletal muscle, by using cycle-limited RT-PCR (28 cycle-amplified), suggesting that MAWBP may be expressed ubiquitously, except for skeletal muscle, although the level of expression varied. In this experiment, genomic DNA may not have been amplified, because primers designed from the noncoding region of MAWBP could not amplify (data not shown). Considering its expression profile, MAWBP may be involved in the basic functions of many cells.
To determine the chromosomal localization of the MAWBP gene, PCR-based monochromosomal somatic cell hybrid mapping (Quantum, Montreal, Quebec, Canada) was performed with a set of 3Ј untranslated region (UTR) primers (5Ј Ͼ TGACAGCCTAGAGGT Ͻ 3Ј and 5Ј Ͼ TGCTACGATTACAGGCAT Ͻ 3Ј, corresponding to the nt from 911 to 1098). This study indicated that the MAWBP gene is located on human chromosome 10 (Fig. 3A) . To refine the further subchromosomal location of the gene, the radiation hybrid (RH) panels (Stanford G3 and Genebridge 4) were utilized. Both of the linkage analyses of the PCR results (the data vector for MAWBP of the Stanford G3 and the Genebridge 4 RH panels: 11000 00010 00001 00010 00000 00000 00010 00001 00111 00100 00101 11100 01000 10010 00000 00010 101 and 00011 10010 00000 00010 11101 01110 11001 11000 01010 00100 00000 10000 01101 00100 01010 00000 11100 01000 111, respectively) showed consistently that the MAWBP gene was linked to several markers adjacent to the marker D10S210 in chromosome 10q21.1, with lod score values higher than 5.6. The most likely order of the refined loci is shown in Fig. 3B . Other genes that have been mapped to chromosome 10q21.1 near the MAWBP gene include the myxoid chondrosarcoma translocation gene (Shen et al. 1990 ) and the Charcot-Marie-Tooth disease type 1D (CMT1D) gene (De Jonghe et al. 1999 ).
Although there is no evidence of MAWBP involvement in the genesis of these diseases, our precise chromosomal positioning data could contribute toward positional candidate approaches for these disease genes linked to this locus. Future studies will address the biological role of MAWBP in this regard, with reference to MAWD-binding.
